ArticleTransfusion2025
How do I analyze the role of red blood cell transfusions on clinical outcome in anemic patients? Disentangling the effect of red blood cell transfusions from pre-operative anemia on post-operative outcome.
Article in Transfusion, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Embracing complexity in transfusion research.Vox sanguinis · 2026Review
- Pre-operative anaemia, red blood cell transfusion and mortality after cardiac surgery: a Netherlands Heart Registration mediation analysis.Anaesthesia · 2026Article
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundPreoperative anemia is associated with worse clinical postoperative outcomes and a higher risk of receiving red blood cell (RBC) transfusions. It is challenging to disentangle the effect of preoperative anemia from the effect of receiving RBC transfusions on postoperative clinical outcomes such as length of hospital stay (LOS). When analyzing the association of preoperative anemia on LOS, it is important to be able to analyze RBC transfusions as a mediator in this relationship. In this paper, the background and application of mediation analysis is outlined as a statistical methodology in transfusion medicine research. STUDY DESIGN AND
methodsTo explain the methodology of mediation analysis, a database from a previously reported clinical study was used (So-Osman C. et al. 2014) with anemia as the exposure variable and LOS as the primary outcome. Both the product-of-coefficients method and the change-in-coefficients method are used for mediation analysis, and linear regression models were used.
resultsIn the example of a simplified analysis, two-thirds of the effect could be attributed to mediation. This result was obtained by both the product-of-coefficients method and the change-in-coefficients method. DISCUSSION: Mediation is assessed in a similar way as confounding, but the interpretation of the results is totally different. It is, therefore, of critical importance to distinguish between potential mediators and potential confounders in transfusion research. Since the calculation reported in the results is merely used as an example to show the methodology, e.g. ignoring confounding, the result should not be interpreted as scientific research data.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.